UK markets open in 3 hours 11 minutes

Biofrontera AG (0DOL.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
5.12+1.58 (+44.53%)
At close: 10:34AM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-369
-369
-44,166
37,747
-13,023
-
Depreciation & amortisation
791
791
746
3,290
5,333
-
Deferred income taxes
-
-
-
-
-57
36
Change in working capital
-7,172
-7,172
-5,419
4,052
-1,783
-
Accounts receivable
-
-
-
-
1,514
-673
Inventory
-283
-283
20
-5,938
-1,023
-
Accounts payable
-
-
-
-
-2,573
596
Other working capital
-2,817
-2,817
-4,876
29,810
-3,623
-
Other non-cash items
4,809
4,809
44,903
-10,192
6,440
-
Net cash provided by operating activities
-1,905
-1,905
-3,895
30,439
-2,849
-
Cash flows from investing activities
Investments in property, plant and equipment
-912
-912
-981
-629
-774
-
Acquisitions, net
-
-
0
-41,630
0
-
Net cash used for investing activities
-912
-912
-981
-42,259
2,873
-
Cash flows from financing activities
Debt repayment
0
0
-2,031
-15,000
0
-
Common stock issued
0
0
0
24,667
8,499
-
Dividends paid
-
-
-
-
0
0
Other financing activities
-
-
7,090
-
-406
-3
Net cash used provided by (used for) financing activities
-
-
-
-
5,948
3,455
Net change in cash
-3,296
-3,296
-532
-9,638
5,972
-
Cash at beginning of period
6,376
6,376
6,908
16,546
11,119
-
Cash at end of period
3,080
3,080
6,376
6,908
16,546
-
Free cash flow
Operating cash flow
-1,905
-1,905
-3,895
30,439
-2,849
-
Capital expenditure
-912
-912
-981
-629
-774
-
Free cash flow
-2,817
-2,817
-4,876
29,810
-3,623
-